House Bill 1454 requires the Maryland Department of Aging to hire an independent consultant to study how continuing care retirement communities (CCRCs) and continuing care at-home providers should be licensed and regulated in Maryland. The study must assess which state agency is best positioned to serve as the lead regulator, including the Maryland Insurance Administration, the Department of Aging, the Maryland Department of Health, the Department of Labor, and the Office of the Attorney General. It must also identify the staffing and role needs for those agencies and compare Maryland’s framework with how other states regulate similar providers, including fees, penalties, oversight funding, and broader regulatory trends.
The bill also directs the consultant to compare Maryland’s existing statutes and regulations governing CCRCs and continuing care at-home providers—particularly Title 10, Subtitle 4 of the Human Services Article and related COMAR provisions—with laws in other states. The Department of Aging must submit the study to the Governor and the General Assembly by December 1, 2026. The bill is contingent on a future appropriation in the state budget; if funding is not received by July 1, 2026, the study requirement becomes void. If funding is received in time, the study provision takes effect upon notice and remains in force only through June 30, 2027.
The bill’s practical impact is limited to creating a study rather than immediately changing licensing or regulatory authority. It does not itself transfer oversight, impose new fees, or alter existing statutory duties, but it could lay the groundwork for future legislation affecting the regulation of CCRCs and continuing care at-home providers. It may affect the Department of Aging and the other named agencies by requiring their input and potentially informing future administrative or legislative restructuring.
The available context shows no recorded committee testimony or votes, so there is no documented floor or committee sentiment in the materials provided. Based on the bill’s structure, it appears to be a policy review measure rather than a controversial regulatory overhaul. Any support or opposition would likely center on whether Maryland should expand, consolidate, or reassign oversight of these senior housing and care arrangements, and whether the state should spend funds on a consultant-led study before making substantive changes.
Notable points of contention, if any arise, would likely involve agency jurisdiction, administrative burden, and the value of a study versus direct action. Stakeholders could differ over whether the Maryland Insurance Administration, the Department of Aging, or another agency should lead regulation, and whether the state should adopt stronger oversight, different fee structures, or more robust consumer protections for residents and prospective residents of CCRCs and continuing care at-home programs.
HB1454 would not directly amend the substantive licensing rules for continuing care retirement communities or continuing care at-home providers, but it would temporarily create a state-funded study process within the Department of Aging. The bill references existing authority in Title 10, Subtitle 4 of the Human Services Article and COMAR 32.02.01 and 32.02.02, and it could inform future changes to those statutes and regulations by comparing Maryland’s framework with other states. Its immediate legal effect is contingent and temporary: if funding is appropriated, the study requirement becomes operative; if not, the bill becomes void. The measure primarily affects the Department of Aging and the other named agencies by requiring participation and input, while potentially influencing future oversight of senior living and long-term care providers.
The provided materials show no committee transcript, recorded vote, or formal opposition/support statements, so there is no direct evidence of legislative sentiment in the record supplied. The bill appears to be a neutral, exploratory policy measure focused on evaluating regulatory options rather than imposing immediate mandates on providers. Because it is a study bill with a funding contingency, it is likely to be viewed as lower-risk and more informational than controversial, though any future regulatory recommendations could generate stronger reactions from agencies, providers, and consumer advocates.
The main points of possible contention are who should regulate continuing care retirement communities and continuing care at-home providers, how much authority should rest with the Department of Aging versus the Maryland Insurance Administration or other agencies, and whether the state should invest in a consultant-led study before making policy changes. Another likely issue is the scope of oversight and whether Maryland should adopt stronger fees, penalties, or funding mechanisms similar to other states. Providers may be concerned about future regulatory expansion, while consumer advocates may favor a study that could lead to tighter protections and clearer oversight.